CAPTRUST Financial Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-30,697
Closed -$48K 2254
2022
Q3
$48K Buy
30,697
+28,504
+1,300% +$64.7K ﹤0.01% 1989
2022
Q2
$4K Sell
2,193
-736
-25% -$1.27K ﹤0.01% 4248
2022
Q1
$7K Buy
2,929
+736
+34% +$2.3K ﹤0.01% 4020
2021
Q4
$10K Sell
2,193
-907
-29% -$5.63K ﹤0.01% 3739
2021
Q3
$24K Hold
3,100
﹤0.01% 3052
2021
Q2
$30K Buy
3,100
+829
+37% +$6.6K ﹤0.01% 2845
2021
Q1
$19K Sell
2,271
-6,016
-73% -$63.5K ﹤0.01% 3050
2020
Q4
$57K Buy
8,287
+1,750
+27% +$14.1K ﹤0.01% 1775
2020
Q3
$70K Buy
6,537
+4,887
+296% +$44.7K ﹤0.01% 1514
2020
Q2
$11K Buy
+1,650
New +$6.32K ﹤0.01% 2155
2019
Q4
Sell
-2,000
Closed -$4K 1936
2019
Q3
$4K Hold
2,000
﹤0.01% 1711
2019
Q2
$5K Hold
2,000
﹤0.01% 1666
2019
Q1
$10K Buy
+2,000
New +$5.25K ﹤0.01% 1397

Other funds holding SRNE